Please login to the form below

Not currently logged in
Email:
Password:

SEC

This page shows the latest SEC news and features for those working in and with pharma, biotech and healthcare.

Lilly ends $1.4bn deal with immuno-oncology biotech NextCure

Lilly ends $1.4bn deal with immuno-oncology biotech NextCure

NextCure did not reveal why Lilly decided to terminate the agreement, saying in a brief US Securities and Exchange Commission (SEC) filing:. ... Shares in the biotech fell shortly after the SEC filing was released – the company is also due to present

Latest news

More from news
Approximately 2 fully matching, plus 63 partially matching documents found.

Latest Intelligence

  • Creating a successful global compliance programme Creating a successful global compliance programme

    The importance of effective compliance programmes was highlighted in the DOJ and SEC’s Resource Guide to the US Foreign Corrupt Practices Act, which describes in detail the hallmarks of a

  • Deal Watch January 2018

    However, in the meantime the US Securities and Exchange Commission (SEC) has issued a lawsuit against some traders for insider trading based on a series of suspicious transactions that made about

  • US health reforms US health reforms

    In March, the Securities and Exchange Commission (SEC) only narrowly blocked this move.

  • Deal Watch - May 2017 Deal Watch - May 2017

    A good example is Abbott’s acquisition of the diagnostics company Alere signed in February 2016.  Two months later Abbott asked Alere to cancel the transaction because of a SEC inquiry ... into accounting issues at Alere and offered $30m to $50m

  • On the road with the millennial HCP On the road with the millennial HCP

    Yeah I'll put Andy on. Just hang on a sec, he's just sorting our next lift.”.

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • SALES ACCELERANT

    We help companies to engage prim/sec care healthcare professionals more efficiently and effectively to drive sales growth.

  • SEC Pharma

    Analysis, SEC can assist wherever you are looking to hire or work throughout the UK and Europe.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

EU health fund
An EU emergency health fund to limit the impact of future crises
Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...

Infographics